• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用类器官模型研究肝癌中的肠-肝轴。

Examining the gut-liver axis in liver cancer using organoid models.

作者信息

Shek Dmitrii, Chen Dishen, Read Scott A, Ahlenstiel Golo

机构信息

Blacktown Clinical School, Western Sydney University, Blacktown, NSW, Australia; Storr Liver Centre, The Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia.

Storr Liver Centre, The Westmead Institute for Medical Research, University of Sydney, Westmead, NSW, Australia.

出版信息

Cancer Lett. 2021 Jul 10;510:48-58. doi: 10.1016/j.canlet.2021.04.008. Epub 2021 Apr 20.

DOI:10.1016/j.canlet.2021.04.008
PMID:33891996
Abstract

The World Health Organization predicts that by 2030 liver cancer will cause 1 million deaths annually, thus becoming the third most lethal cancer worldwide. Hepatocellular carcinoma and cholangiocarcinoma are the two major primary cancer subtypes involving the liver. Both are often diagnosed late, and hence response to treatment and survival are poor. It is therefore of utmost importance to understand the mechanisms by which liver cancers initiate and progress. The causes of primary liver cancer are diverse, resulting primarily from obesity, chronic alcohol abuse or viral hepatitis. Importantly, both alcohol and high fat diet can promote intestinal permeability, enabling microbial translocation from the gut into the liver. As a result, these microbial antigens and metabolites exacerbate hepatic inflammation and fibrosis, increasing the risk of primary liver cancer. Organoids are primary, three-dimensional, stem cell derived liver models that can recapitulate many of the disease phenotypes observed in vivo. This review aims to summarize the advantages of organoid culture to examine the gut-liver axis with respect to cancer initiation and progression. In particular, the use of gut and liver organoid mono- and co-cultures together and with immune cell populations to best recapitulate disease mechanisms and develop therapeutic interventions.

摘要

世界卫生组织预测,到2030年,肝癌每年将导致100万人死亡,从而成为全球第三大致命癌症。肝细胞癌和胆管癌是涉及肝脏的两种主要原发性癌症亚型。这两种癌症通常在晚期才被诊断出来,因此对治疗的反应和生存率都很差。因此,了解肝癌发生和发展的机制至关重要。原发性肝癌的病因多种多样,主要源于肥胖、长期酗酒或病毒性肝炎。重要的是,酒精和高脂肪饮食都会增加肠道通透性,使微生物从肠道转移到肝脏。因此,这些微生物抗原和代谢产物会加剧肝脏炎症和纤维化,增加原发性肝癌的风险。类器官是源自原代、三维干细胞的肝脏模型,能够重现许多在体内观察到的疾病表型。本综述旨在总结类器官培养在研究肠道-肝脏轴与癌症发生和发展方面的优势。特别是,将肠道和肝脏类器官单培养和共培养,以及与免疫细胞群体一起使用,以最好地重现疾病机制并开发治疗干预措施。

相似文献

1
Examining the gut-liver axis in liver cancer using organoid models.使用类器官模型研究肝癌中的肠-肝轴。
Cancer Lett. 2021 Jul 10;510:48-58. doi: 10.1016/j.canlet.2021.04.008. Epub 2021 Apr 20.
2
Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model.非酒精性脂肪性肝炎(NASH)小鼠模型不同阶段的原发性肝类器官培养的功效
Biomaterials. 2020 Apr;237:119823. doi: 10.1016/j.biomaterials.2020.119823. Epub 2020 Jan 27.
3
[Role of gut-liver-immune axis in the pathogenesis of nonalcoholic steatohepatitis].肠-肝-免疫轴在非酒精性脂肪性肝炎发病机制中的作用
Zhonghua Gan Zang Bing Za Zhi. 2021 Jun 20;29(6):505-509. doi: 10.3760/cma.j.cn501113-20210430-00215.
4
Gut microbiome in HCC - Mechanisms, diagnosis and therapy.肝癌中的肠道微生物组:机制、诊断与治疗。
J Hepatol. 2020 Feb;72(2):230-238. doi: 10.1016/j.jhep.2019.08.016.
5
Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.肠道微生物失调通过肠-肝轴与肝细胞癌相关。
Hepatobiliary Pancreat Dis Int. 2019 Feb;18(1):19-27. doi: 10.1016/j.hbpd.2018.11.002. Epub 2018 Nov 22.
6
Organoid Models of Human Liver Cancers Derived from Tumor Needle Biopsies.从肿瘤活检针获得的人类肝癌类器官模型。
Cell Rep. 2018 Jul 31;24(5):1363-1376. doi: 10.1016/j.celrep.2018.07.001.
7
Modeling liver cancer and therapy responsiveness using organoids derived from primary mouse liver tumors.利用源自原发性小鼠肝肿瘤的类器官对肝癌和治疗反应进行建模。
Carcinogenesis. 2019 Mar 12;40(1):145-154. doi: 10.1093/carcin/bgy129.
8
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
9
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.槲皮素对高脂饮食诱导的小鼠非酒精性脂肪性肝病的保护作用是通过调节肠道微生物群失衡和相关肠-肝轴激活来介导的。
Free Radic Biol Med. 2017 Jan;102:188-202. doi: 10.1016/j.freeradbiomed.2016.11.037. Epub 2016 Nov 25.
10
Gut organoids: mini-tissues in culture to study intestinal physiology and disease.肠道类器官:培养中的迷你组织,用于研究肠道生理学和疾病。
Am J Physiol Cell Physiol. 2019 Sep 1;317(3):C405-C419. doi: 10.1152/ajpcell.00300.2017. Epub 2019 Jun 19.

引用本文的文献

1
Pathway-specific polygenic scores substantially increase the discovery of gene-adiposity interactions impacting liver biomarkers.特定通路的多基因评分显著增加了对影响肝脏生物标志物的基因与肥胖相互作用的发现。
medRxiv. 2025 May 21:2025.05.19.25327939. doi: 10.1101/2025.05.19.25327939.
2
Insights into the gut-liver axis: mechanisms and emerging therapies in hepatocellular carcinoma.洞悉肠-肝轴:肝细胞癌的机制与新兴疗法
Front Pharmacol. 2025 May 19;16:1595853. doi: 10.3389/fphar.2025.1595853. eCollection 2025.
3
Advances in the Development and Application of Human Organoids: Techniques, Applications, and Future Perspectives.
人类类器官的开发与应用进展:技术、应用及未来展望
Cell Transplant. 2025 Jan-Dec;34:9636897241303271. doi: 10.1177/09636897241303271.
4
Exploring the effects of gut microbiota on cholangiocarcinoma progression by patient-derived organoids.通过患者来源的类器官探索肠道微生物群对胆管癌进展的影响。
J Transl Med. 2025 Jan 9;23(1):34. doi: 10.1186/s12967-024-06012-x.
5
Prognostic Hypoxia-Angiogenesis-Related Gene Signature in Hepatocellular Carcinoma, in Which HILPDA Contributes to Tumor Progression.肝细胞癌中与缺氧-血管生成相关的预后基因特征,其中HILPDA促进肿瘤进展。
J Inflamm Res. 2024 Aug 27;17:5663-5683. doi: 10.2147/JIR.S476388. eCollection 2024.
6
Six new polyphenolic metabolites isolated from the and their cytotoxicity against HepG2 cells.从……中分离出的六种新的多酚类代谢产物及其对HepG2细胞的细胞毒性。 (注:原文中“from the ”后面缺失具体内容)
Front Nutr. 2024 Apr 24;11:1390256. doi: 10.3389/fnut.2024.1390256. eCollection 2024.
7
Intestinal Barrier Dysfunction and Gut Microbiota in Non-Alcoholic Fatty Liver Disease: Assessment, Mechanisms, and Therapeutic Considerations.非酒精性脂肪性肝病中的肠道屏障功能障碍与肠道微生物群:评估、机制及治疗考量
Biology (Basel). 2024 Apr 6;13(4):243. doi: 10.3390/biology13040243.
8
Comprehensive bibliometric and visualized analysis of research on gut-liver axis published from 1998 to 2022.1998年至2022年发表的肠道-肝脏轴研究的综合文献计量学与可视化分析
Heliyon. 2024 Mar 8;10(6):e27819. doi: 10.1016/j.heliyon.2024.e27819. eCollection 2024 Mar 30.
9
Genetic alterations in the neuronal development genes are associated with changes of the tumor immune microenvironment in pancreatic cancer.神经元发育基因的遗传改变与胰腺癌肿瘤免疫微环境的变化有关。
Ann Pancreat Cancer. 2023 Nov;6(10). doi: 10.21037/apc-23-13. Epub 2023 Nov 20.
10
PGK1 is a potential biomarker for early diagnosis and prognosis of hepatocellular carcinoma.磷酸甘油酸激酶1是肝细胞癌早期诊断和预后的潜在生物标志物。
Oncol Lett. 2024 Jan 19;27(3):109. doi: 10.3892/ol.2024.14242. eCollection 2024 Mar.